Copyright
©The Author(s) 2018.
World J Gastroenterol. Mar 21, 2018; 24(11): 1269-1277
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1269
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1269
Prior to DAA treatment (baseline) | Post-SVR 12 | P1 value | |
Demographics | |||
Male | 49 (48) | 49 (48) | NS |
Age (yr, mean ± SD) | 60.3 ± 10.7 | 60.3 ± 10.7 | NS |
White | 37 (37) | 37 (37) | NS |
Hispanic | 26 (26) | 26 (26) | NS |
African American | 13 (13) | 13 (13) | NS |
Asian | 7 (7) | 7 (7) | NS |
Other | 2 (2) | 2 (2) | NS |
Declined | 16 (15) | 16 (15) | NS |
Clinical | |||
Hypertension | 45 (43) | 45 (43) | NS |
Type 2 diabetes | 13 (12.3) | 13 (12.3) | NS |
Dyslipidemia | 8 (7.5) | 8 (7.5) | NS |
Anthropometric (mean ± SD) | |||
Body mass index (kg/m2) | 27.6 ± 6.9 | 27.5 ± 6.9 | NS |
Weight (Lbs.) | 174.9 ± 46.9 | 172.7 ± 44.5 | NS |
Laboratory panel (mean ± SD) | |||
HCV vial load log10 IU/mL | 6.2 ± 0.9 | 0.0 ± 0.0 | < 0.0001 |
HCV genotype | |||
Genotype 1 | 86 (85) | ||
Genotype 2 | 15 (14) | ||
Genotype 4 | 1 (1) | ||
AST (U/L) | 51.8 ± 41.1 | 21.5 ± 8.0 | < 0.0001 |
ALT (U/L) | 63.1 ± 62.6 | 17.8 ± 12.3 | < 0.0001 |
Alkaline phosphatase (U/L) | 77.5 ± 34.0 | 71.0 ± 24.3 | 0.004 |
Albumin (g/dL) | 4.3 ± 0.4 | 4.4 ± 0.4 | NS |
Bilirubin, total (mg/dL) | 0.6 ± 0.2 | 0.6 ± 0.3 | NS |
Fasting glucose (mg/dL) | 99.1 ± 30.1 | 102.1 ± 23.5 | NS |
FibroScan (mean ± SD) | |||
Fibrosis Score (kPa) | 7.4 ± 1.9 | 6.1 ± 3.6 | 0.013 |
IQR (%) | 12.6 ± 4.9 | 12.3 ± 5.5 | NS |
- Citation: Noureddin M, Wong MM, Todo T, Lu SC, Sanyal AJ, Mena EA. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals. World J Gastroenterol 2018; 24(11): 1269-1277
- URL: https://www.wjgnet.com/1007-9327/full/v24/i11/1269.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i11.1269